Mao W - Search Results

1

Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?

Xu Y, Yu X, Chen Q, Mao W. Xu Y, et al. Among authors: mao w. World J Surg Oncol. 2012 Aug 25;10:173. doi: 10.1186/1477-7819-10-173. World J Surg Oncol. 2012. PMID: 22920951 Free PMC article. Review.

2

Concurrent radiotherapy with gefitinib in elderly patients with esophageal squamous cell carcinoma: Preliminary results of a phase II study.

Xu Y, Zheng Y, Sun X, Yu X, Gu J, Wu W, Zhang G, Hu J, Sun W, Mao W. Xu Y, et al. Among authors: mao w. Oncotarget. 2015 Nov 10;6(35):38429-39. doi: 10.18632/oncotarget.5193. Oncotarget. 2015. PMID: 26392415 Free PMC article. Clinical Trial.

3

Phase II study of neoadjuvant therapy with nab-paclitaxel and cisplatin followed by surgery in patients with locally advanced esophageal squamous cell carcinoma.

Fan Y, Jiang Y, Zhou X, Chen Q, Huang Z, Xu Y, Gong L, Yu H, Yang H, Liu J, Lei T, Zhao Q, Mao W. Fan Y, et al. Among authors: mao w. Oncotarget. 2016 Aug 2;7(31):50624-50634. doi: 10.18632/oncotarget.9562. Oncotarget. 2016. PMID: 27244882 Free PMC article. Clinical Trial.

4

Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study.

Gong L, Mao W, Chen Q, Jiang Y, Fan Y. Gong L, et al. Among authors: mao w. Cancer Chemother Pharmacol. 2019 Apr;83(4):639-647. doi: 10.1007/s00280-019-03769-7. Epub 2019 Jan 14. Cancer Chemother Pharmacol. 2019. PMID: 30643929

5

Prognostic Nomogram for Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy.

Su D, Zhou X, Chen Q, Jiang Y, Yang X, Zheng W, Tao K, Wu J, Yan Z, Liu L, Wu S, Mao W. Su D, et al. Among authors: mao w. PLoS One. 2015 Apr 20;10(4):e0124437. doi: 10.1371/journal.pone.0124437. eCollection 2015. PLoS One. 2015. PMID: 25893524 Free PMC article.

6

Factors influencing the risk of recurrence in patients with esophageal carcinoma treated with surgery: A single institution analysis consisting of 1002 cases.

Xu Y, Chen Q, Yu X, Zhou X, Zheng X, Mao W. Xu Y, et al. Among authors: mao w. Oncol Lett. 2013 Jan;5(1):185-190. doi: 10.3892/ol.2012.1007. Epub 2012 Oct 30. Oncol Lett. 2013. PMID: 23255917 Free PMC article.

7

Analysis of new N-category on prognosis of oesophageal cancer with positive lymph nodes in a Chinese population.

Xu Y, Jiang Y, Yu X, Chen Q, Zhou X, Mao W. Xu Y, et al. Among authors: mao w. Radiol Oncol. 2013 Mar;47(1):63-70. doi: 10.2478/v10019-012-0039-6. Epub 2013 Feb 1. Radiol Oncol. 2013. PMID: 23450452 Free PMC article.

8

Prognostic impact of postoperative radiation in patients undergoing radical esophagectomy for pathologic lymph node positive esophageal cancer.

Xu Y, Liu J, Du X, Sun X, Zheng Y, Chen J, Li B, Liu W, Jiang H, Mao W. Xu Y, et al. Among authors: mao w. Radiat Oncol. 2013 May 8;8:116. doi: 10.1186/1748-717X-8-116. Radiat Oncol. 2013. PMID: 23656920 Free PMC article.

9

Role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of esophageal carcinoma and the suggested mechanisms of action.

Xu Y, Sheng L, Mao W. Xu Y, et al. Among authors: mao w. Oncol Lett. 2013 Jan;5(1):19-24. doi: 10.3892/ol.2012.994. Epub 2012 Oct 24. Oncol Lett. 2013. PMID: 23255886 Free PMC article.

10

Analysis of Clinical and Dosimetric Factors Influencing Radiation-Induced Lung Injury in Patients with Lung Cancer.

Han S, Gu F, Lin G, Sun X, Wang Y, Wang Z, Lin Q, Weng D, Xu Y, Mao W. Han S, et al. Among authors: mao w. J Cancer. 2015 Sep 15;6(11):1172-8. doi: 10.7150/jca.12314. eCollection 2015. J Cancer. 2015. PMID: 26516366 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,029 results

Search Page

Filters